ArticleTransplantation and cellular therapy2022

Feasibility and Efficacy of Partially Replacing Post-Transplantation Cyclophosphamide with Bendamustine in Pediatric and Young Adult Patients Undergoing Haploidentical Bone Marrow Transplantation.

Emmanuel Katsanis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.